Work

Phase II study of tosedostat with cytarabine or decitabine in newly diagnosed older patients with acute myeloid leukaemia or high‐risk MDS

Year: 2015

Type: article

Study design: Clinical Trial

Source: British Journal of Haematology

DOI: 10.1111/bjh.13829

Authors: Raya Mawad, Pamela S. Becker, Paul Hendrie, Bart Scott, Brent L. Wood, Carol Dean, Vicky Sandhu, Hans Joachim Deeg, Roland Walter, Lixia Wang, Han Myint, Jack W. Singer, Elihu Estey, John M. Pagel

Institutions: University of Washington, Fred Hutch Cancer Center, CTI BioPharma (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Damon Runyon Cancer Research Foundation, Leukemia and Lymphoma Society, National Institutes of Health, National Cancer Institute

Award: CD45 Pretargeted Radioimmunotherapy for AML

OpenAlex ID: W2256972210

FWCI: 3.619

Cites: 17

Cited by: 32

Related to: 10